In an analyst note made public on Monday, 13 February, AstraZeneca PLC (LON:AZN) stock had its “Buy” Rating reiterated by research analysts at Liberum Capital. They currently have a GBX 5100.00 PT on company. Liberum Capital’s target suggests a potential upside of 9.77% from the company’s previous close.
FREEZE TAG INCORPORATED (OTCMKTS:FRZT) had a decrease of 91.24% in short interest. FRZT’s SI was 4,800 shares in February as released by FINRA. Its down 91.24% from 54,800 shares previously. It closed at $0.0002 lastly. It is down 60.00% since July 29, 2016 and is downtrending. It has underperformed by 69.34% the S&P500.
Freeze Tag, Inc. is engaged in creating mobile social games that are fun and engaging for all ages. The company has market cap of $131,370. Players can download the games for free or they can purchase virtual items and additional features within the game to increase the fun factor. It currently has negative earnings. The Company’s games encourage players to compete and engage with their friends on social networks, such as Facebook and Twitter.
About 412,844 shares traded. AstraZeneca plc (LON:AZN) has declined 8.70% since July 29, 2016 and is downtrending. It has underperformed by 18.03% the S&P500.
AstraZeneca PLC is a biopharmaceutical company. The company has market cap of 59.07 billion GBP. The Firm focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in various therapy areas, including respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology, as well as in infection, neuroscience and gastrointestinal areas. It has a 20.91 P/E ratio. The Firm has its activities in over 100 countries.
Among 31 analysts covering AstraZeneca PLC (LON:AZN), 15 have Buy rating, 4 Sell and 12 Hold. Therefore 48% are positive. AstraZeneca PLC has GBX 7000 highest and GBX 3700 lowest target. GBX 4834.60’s average target is 4.27% above currents GBX 4636.5 stock price. AstraZeneca PLC had 402 analyst reports since July 23, 2015 according to SRatingsIntel. Oddo & Cie upgraded AstraZeneca plc (LON:AZN) rating on Thursday, February 11. Oddo & Cie has “Buy” rating and GBX 5440 target. The firm earned “Buy” rating on Friday, May 20 by Deutsche Bank. The firm has “Reduce” rating given on Monday, November 16 by Kepler Cheuvreux. BNP Paribas maintained AstraZeneca plc (LON:AZN) rating on Friday, January 8. BNP Paribas has “Outperform” rating and GBX 5500 target. The rating was maintained by Credit Suisse with “Neutral” on Tuesday, August 11. Deutsche Bank maintained the stock with “Buy” rating in Tuesday, June 7 report. JP Morgan maintained the shares of AZN in report on Tuesday, December 6 with “Neutral” rating. The firm has “Outperform” rating by BNP Paribas given on Tuesday, November 17. The rating was maintained by Cantor Fitzgerald with “Buy” on Thursday, February 2. Pareto Securities maintained AstraZeneca plc (LON:AZN) on Thursday, January 28 with “Sell” rating.
The post Liberum Capital Keeps a “Buy” Rating on AstraZeneca PLC (LON:AZN) and GBX 5100.00 Target; FREEZE TAG (FRZT) Shorts Down By 91.24% appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2017/02/27/liberum-capital-keeps-a-buy-rating-on-astrazeneca-plc-lonazn-and-gbx-5100-00-target-freeze-tag-frzt-shorts-down-by-91-24/
No comments:
Post a Comment